Back
to sessions
Sep 30
Science Highlights
MODERATOR(S)
Michelle Mierzwa, MD - University of Michigan
session DESCRIPTION
Please note: The abstracts listed below will not be presented by the authors during this session. Instead, a designated discussant will highlight and discuss key findings and takeaways from these abstracts.
Credits
| AMA PRA Category 1 Credits: | 0.50 |
| CAMPEP Credits: | 0.50 |
| MDCB Credits: | 0.50 |
Presentations
-
10:45am - 10:48am ET
HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA) with Protons or Photons vs. Standard of Care for Head and Neck Squamous Cell Carcinoma: A Randomized Trial
Speaker: Jos Elbers, MD, PhD - Erasmus Medical Center, Rotterdam -
10:48am - 10:51am ET
Pooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer
Speaker: Nancy Lee, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York -
10:51am - 10:54am ET
C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival
Speaker: Gerard Adams, MB, ChB, FRANZCR - Genesis Care Bundaberg, Bundaberg -
10:54am - 10:57am ET
-
10:57am - 11:00am ET
NRG-HN009 Randomized Phase II/III Trial of RT + Cisplatin Q3 Weeks vs RT + Cisplatin Weekly for Patients with Locoregionally Advanced SCCHN: p16-Negative Phase II Toxicity Results
Speaker: Paul Harari, MD, FASTRO - University of Wisconsin School of Medicine and Public Health, Madison -
11:00am - 11:03am ETSpeaker: Michelle Mierzwa, MD - University of Michigan, Ann Arbor